Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 13

1.

Three novel mutations of CHD7 gene in two turkish patients with charge syndrome; A double point mutation and an insertion.

Bozkaya OG, Ataman E, Randa C, Cura DO, Gürsoy S, Aksel O, Ulgenalp A.

Balkan J Med Genet. 2015 Dec 30;18(1):65-70. doi: 10.1515/bjmg-2015-0007.

2.

SEL1L SNP rs12435998, a predictor of glioblastoma survival and response to radio-chemotherapy.

Mellai M, Cattaneo M, Storaci AM, Annovazzi L, Cassoni P, Melcarne A, De Blasio P, Schiffer D, Biunno I.

Oncotarget. 2015 May 20;6(14):12452-67.

3.

Establishing pluripotency in early development.

Paranjpe SS, Veenstra GJ.

Biochim Biophys Acta. 2015 Jun;1849(6):626-36. doi: 10.1016/j.bbagrm.2015.03.006. Review.

4.

Unexplored potentials of epigenetic mechanisms of plants and animals-theoretical considerations.

Seffer I, Nemeth Z, Hoffmann G, Matics R, Seffer AG, Koller A.

Genet Epigenet. 2013 Jun 30;5:23-41. doi: 10.4137/GEG.S11752. Review.

5.

SWI/SNF chromatin remodeling enzymes in melanocyte differentiation and melanoma.

Mehrotra A, Mehta G, Aras S, Trivedi A, de la Serna IL.

Crit Rev Eukaryot Gene Expr. 2014;24(2):151-61. Review.

6.

The computational analysis of human testis transcriptome reveals closer ties to pluripotency.

Anand M, Prasad BV.

J Hum Reprod Sci. 2012 Sep;5(3):266-73. doi: 10.4103/0974-1208.106339.

7.

Suv4-20h histone methyltransferases promote neuroectodermal differentiation by silencing the pluripotency-associated Oct-25 gene.

Nicetto D, Hahn M, Jung J, Schneider TD, Straub T, David R, Schotta G, Rupp RA.

PLoS Genet. 2013;9(1):e1003188. doi: 10.1371/journal.pgen.1003188.

8.

Epigenetic mechanisms in cardiac development and disease.

Vallaster M, Vallaster CD, Wu SM.

Acta Biochim Biophys Sin (Shanghai). 2012 Jan;44(1):92-102. doi: 10.1093/abbs/gmr090. Review.

9.

Epigenetic landscape of pluripotent stem cells.

Han JW, Yoon YS.

Antioxid Redox Signal. 2012 Jul 15;17(2):205-23. doi: 10.1089/ars.2011.4375. Review.

10.

Histone deacetylase 9 is a negative regulator of adipogenic differentiation.

Chatterjee TK, Idelman G, Blanco V, Blomkalns AL, Piegore MG Jr, Weintraub DS, Kumar S, Rajsheker S, Manka D, Rudich SM, Tang Y, Hui DY, Bassel-Duby R, Olson EN, Lingrel JB, Ho SM, Weintraub NL.

J Biol Chem. 2011 Aug 5;286(31):27836-47. doi: 10.1074/jbc.M111.262964.

11.

Teashirt-3, a novel regulator of muscle differentiation, associates with BRG1-associated factor 57 (BAF57) to inhibit myogenin gene expression.

Faralli H, Martin E, Coré N, Liu QC, Filippi P, Dilworth FJ, Caubit X, Fasano L.

J Biol Chem. 2011 Jul 1;286(26):23498-510. doi: 10.1074/jbc.M110.206003.

12.

Chromatin structure of pluripotent stem cells and induced pluripotent stem cells.

Delgado-Olguín P, Recillas-Targa F.

Brief Funct Genomics. 2011 Jan;10(1):37-49. doi: 10.1093/bfgp/elq038. Review.

13.

Modulation of extracellular matrix/adhesion molecule expression by BRG1 is associated with increased melanoma invasiveness.

Saladi SV, Keenen B, Marathe HG, Qi H, Chin KV, de la Serna IL.

Mol Cancer. 2010 Oct 22;9:280. doi: 10.1186/1476-4598-9-280.

Items per page

Supplemental Content

Support Center